User:Kgarcia54/Medication costs
By region
United States
Canada
To provide context for the medication costs in Canada, the country is a member of the OECD, an international organization that consists of 38 countries which includes countries like the United States, Australia, Germany, and more. Among these 38 countries, Canada ranks number three in medication costs in the OECD.[1] The Government of Canada found that during the 2020-2021 year, the country had spent 12.3 billion dollars on medication costs. [2] In Canada, each province and territory publicly funds their own insurance plan rather than a national insurance plan. [3] With differing insurance plans, the medication costs the public varies from area to area. [4]
In Canada, the medication pricing is overseen by the Patented Medicine Prices Review Board (PMPRB), which monitors the prices set for patented drugs.[5] One way the PMPRB evaluates whether drug pricing by patentees is excessive by considering international drug pricing. [6] The PMPRB also compares the price of the drug to a similar market.[7] However, the patentees do not need approval of drug pricing with the PMPRB before listing drugs for sale. [8]
![]() | This is the sandbox page where you will draft your initial Wikipedia contribution.
If you're starting a new article, you can develop it here until it's ready to go live. If you're working on improvements to an existing article, copy only one section at a time of the article to this sandbox to work on, and be sure to use an edit summary linking to the article you copied from. Do not copy over the entire article. You can find additional instructions here. Remember to save your work regularly using the "Publish page" button. (It just means 'save'; it will still be in the sandbox.) You can add bold formatting to your additions to differentiate them from existing content. |
Article Draft
Lead
Article body
References
- ^ Canada, Health (2004-05-28). "Prescription drug pricing and costs". www.canada.ca. Retrieved 2024-07-27.
- ^ Canada, Patented Medicine Prices Review Board (2023-01-31). "Increased use of higher-cost medicines continues to put pressure on Canadian public drug plans". www.canada.ca. Retrieved 2024-07-27.
- ^ Clement, Fiona; Memedovich, Katherine A. (2018-05). "Drug coverage in Canada: gaps and opportunities". Journal of Psychiatry & Neuroscience : JPN. 43 (3): 148–150. doi:10.1503/jpn.180051. ISSN 1180-4882. PMC 5915235. PMID 29688870.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Anis, Aslam H.; Guh, Daphne; Wang, Xiao-hua (2001-04). "A Dog's Breakfast:: Prescription Drug Coverage Varies Widely Across Canada". Medical Care. 39 (4): 315. ISSN 0025-7079.
{{cite journal}}
: Check date values in:|date=
(help) - ^ Canada, Patented Medicine Prices Review Board (2020-10-22). "Patented Medicine Prices Review Board". www.canada.ca. Retrieved 2024-07-27.
- ^ Zhang, Wei; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H. (2024-06-01). "The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis". Health Policy. 144: 105064. doi:10.1016/j.healthpol.2024.105064. ISSN 0168-8510.
- ^ "Price Review". pmprb-cepmb.gc.ca. 2014-03-24. Retrieved 2024-07-27.
- ^ Canada, Patented Medicine Prices Review Board (2021-09-07). "Regulatory Process". www.canada.ca. Retrieved 2024-07-27.